JA

Jis Abraham

Active Director Director DIN 10208928
DIN 10208928 First appointment Jun 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Jis Abraham

Data last updated:

Jis Abraham is a Director at Divine Mercy Eye Care Private Limited (since 2023). The company operates in Healthcare. Divine Mercy Eye Care Private Limited reported revenue of ₹2,546 (FY 2024).

DIN 10208928
Primary Designation Director
Industry Healthcare
First Appointment 21 Jun 2023
Oldest Company Age 3 yrs
Largest company Divine Mercy Eye Care Private Limited · ₹2,546 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jun 20232023₹2,546 (FY 2024)Active

Board colleagues of Jis Abraham

NameDINCompanyDesignation
Prince Eapen10208927Divine Mercy Eye Care Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Divine Mercy Eye Care Private Limited
Premium access

Shareholding and investment profile for Jis Abraham

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jis Abraham

Jis Abraham currently holds 1 directorship: Divine Mercy Eye Care Private Limited (Director, since 21 Jun 2023, revenue ₹2,546 (FY 2024)).

Jis Abraham was first appointed on 21 Jun 2023 as Director at Divine Mercy Eye Care Private Limited.

The current boards of Jis Abraham's companies include Prince Eapen (Divine Mercy Eye Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available